Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00007527 |
|
Recruitment Status :
Completed
First Posted : January 1, 2001
Last Update Posted : January 21, 2009
|
Sponsor:
US Department of Veterans Affairs
Collaborators:
National Institute on Drug Abuse (NIDA)
Reckitt and Colman
Information provided by:
VA Office of Research and Development
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | January 2002 |